LauraJ.EssermanMD
General Surgery • San Francisco, CASurgical Oncology (Other than Breast)
Associate Professor of Surgery, UCSF
Dr. Esserman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Divisadero Street
San Francisco, CA 94143Phone+1 415-353-7070
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Surgery, 1983 - 1991
Stanford University School of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 1984 - 2026
HI State Medical License 1989 - 1990- American Board of Surgery Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Redbook Magazine: Top Breast Cancer Doctors Castle Connolly, 2001
- Join now to see all
Clinical Trials
- Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery Start of enrollment: 2002 Feb 01
- Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ Start of enrollment: 2002 Feb 19
- Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer Start of enrollment: 2006 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast Cancers.Alejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai, Christina Yau, Michal Marczyk
Clinical Cancer Research. 2025-01-17 - Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In Situ: A Phase 1 Nonrandomized Clinical Trial.Kirithiga Ramalingam, Rachel Woody, Alexa Glencer, Christopher J Schwartz, Hidetoshi Mori
JAMA Oncology. 2025-01-16 - Implementation and impact of an electronic patient reported outcomes system in a phase II multi-site adaptive platform clinical trial for early-stage breast cancer.Anna Northrop, Anika Christofferson, Saumya Umashankar, Michelle Melisko, Paolo Castillo
Journal of the American Medical Informatics Association. 2025-01-01
Journal Articles
- Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 PatientsMerisa Piper, Jasmine Wong, Hani Sbitany, Cheryl Ewing, Michael Alvarado, Laura Esserman, Robert Foster, Annals of Surgical Oncology
Lectures
- The Role of Molecular Biomarkers in the Treatment of the High Risk Patient/I-SPY TrailSan Francisco, CA - 10/25/2014
Other
- Clinical features, diagnosis, and staging of newly diagnosed breast cancerEsserman LJ, Joe BN
http://www.uptodate.com/contents/clinical-features-diagnosis-and-staging-of-newly-diagnosed-breast-c
UpToDate, Wolters Kluwer Health - 2013-01-28 - Breast biopsyEsserman LJ, Joe BN
http://www.uptodate.com/contents/breast-biopsy
UpToDate, Wolters Kluwer Health - 2013-04-01 - Diagnostic evaluation of women with suspected breast cancerEsserman LJ, Joe BN
http://www.uptodate.com/contents/diagnostic-evaluation-of-women-with-suspected-breast-cancer
UpToDate, Wolters Kluwer Health - 2013-04-01
Press Mentions
The Scope of the 'Cancer' Label DebateJanuary 30th, 2025- When ‘Cancer’ Gets in the Way of TreatmentJanuary 28th, 2025
- Pembrolizumab-mRNA-2752 Approach Seems Safe; Disease Regression PossibleJanuary 21st, 2025
- Join now to see all
Grant Support
- Integrated Biomarkers To Characterize Breast Cancer RiskNational Cancer Institute2004–2009
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
